Key result
Five-gene fibroblast signature discriminates heart failure with ~0.94 AUC, but shows mixed external validation.
Why the study?
Fibroblast activation and extracellular matrix remodeling are central to ventricular remodeling in heart failure, but fibroblast heterogeneity complicates the prioritization of disease-associated genes.
Integrating single-cell and multi-cohort bulk transcriptomics identified SMOC2, FNDC1, KCNN3, SFRP4, and LUM as key fibroblast-associated candidate genes in heart failure, alongside a recurrent DCN extracellular-matrix network response.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for HF fibroblast gene targets; leaves open clinical relevance pending functional validation.
Background: Fibroblast activation and extracellular matrix (ECM) remodeling are central to ventricular remodeling in heart failure (HF), but fibroblast heterogeneity complicates the prioritization of disease-associated genes. We integrated single-cell and bulk transcriptomic data to prioritize HF fibroblast-associated candidates and evaluate their predicted network effects. Methods: High-dimensional weighted gene co-expression network analysis (hdWGCNA) was performed on GSE288222 fibroblasts, and module-HF associations were evaluated at the subject level. Candidate screening, classifier comparison, and TreeSHAP ranking were conducted in three bulk myocardial cohorts. We assessed robustness using training-fitted batch correction, fully nested cross-validation, repeated feature ranking, and nested leave-one-cohort-out analysis. Candidate-level and fixed-model performance were evaluated in GSE55296 and GSE42955. Hallmark single-sample gene set enrichment analysis (ssGSEA) assessed tissue-level pathway associations. A shared fibroblast network from GSE226314 was analyzed by scTenifoldKnk. Results: The Fibro-M1 module (303 genes) was positively associated with HF across 12 subjects (r = 0.919, FDR = 9.77 × 10−5), and leave-one-subject-out correlations ranged from 0.910 to 0.934. Seventy-four genes entered machine learning, and TreeSHAP prioritized SMOC2, FNDC1, KCNN3, SFRP4, and LUM. Training-fitted preprocessing recovered the same five-gene set; the internal-test AUC was 0.961 (95% CI, 0.924–0.999), and the fully nested five-fold AUC was 0.940 (95% CI, 0.907–0.972). In GSE42955 (24 HF samples and five controls), the locked five-gene SVM yielded an AUC of 0.875 (95% CI, 0.662–1.000). In GSE55296, SMOC2 and SFRP4 were replicated at the expression level, whereas fixed-reference five-gene discrimination was not maintained (AUC = 0.492; 95% CI, 0.240–0.745). Nested leave-one-cohort-out AUCs ranged from 0.863 to 0.959, but selected features differed among rotations. In the pooled fibroblast network, the five virtual knockouts yielded 1, 0, 1, 2, and 2 significant genes, respectively; recurrence of DCN varied across pooled and stratified networks. Conclusions: Integrating fibroblast co-expression structure with multi-cohort transcriptomics prioritized SMOC2, FNDC1, KCNN3, SFRP4, and LUM as HF-associated candidates. Their cross-cohort evidence and predicted network effects were heterogeneous, and model transportability depended on the evaluation platform. The recurrent DCN signal suggests a shared extracellular-matrix network response that deserves further study.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied Heart failure. Five-gene fibroblast signature (SMOC2, FNDC1, KCNN3, SFRP4, and LUM) vs. Non-failing control samples was evaluated on Heart failure classification and discrimination (AUC) (AUC 0.940, 95% CI 0.907-0.972). A five-gene fibroblast signature (SMOC2, FNDC1, KCNN3, SFRP4, LUM) discriminated heart failure with a nested five-fold AUC of 0.940 and external AUCs of 0.875 and 0.492.
Synapse has enriched 10 related papers. Consider them for comparative context: